ScholarLens Back to search
2019•CirculationRequires access

Abstract 13587: Combined Ranolazine and Dofetilide or Ranolazine and Sotalol in the Management of Atrial Fibrillation

Sarfaraz Memon, Sonal Pruthi, Jeffrey Kluger

Open publisher page 0 citations

Abstract

Introduction: Ranolazine, an inhibitor of late-phase sodium current (INA) has been shown to reduce atrial fibrillation (AF) burden. HARMONY trial showed that the combination of ranolazine to dronad...

About this research paper

What this paper is about

Introduction: Ranolazine, an inhibitor of late-phase sodium current (INA) has been shown to reduce atrial fibrillation (AF) burden. HARMONY trial showed that the combination of ranolazine to dronad...

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Introduction: Ranolazine, an inhibitor of late-phase sodium current (INA) has been shown to reduce atrial fibrillation (AF) burden. HARMONY trial showed that the combination of ranolazine to dronad...

Key concepts: Ranolazine, Dofetilide, Medicine, Sotalol, Atrial fibrillation, Cardiology, Internal medicine, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Abstract 13587: Combined Ranolazine and Dofetilide or Ranolazine and Sotalol in the Management of Atrial Fibrillation — Research Paper | ScholarLens